Is it time for comprehensive therapists to change the way they predict heart attacks, strokes, and other atherosclerotic disorders as proposed by the group of prominent cardiologists from the Society for Heart Attack Prevention and Eradication (SHAPE)?

Those proposals are beautifully described in this thoroughgoing unique new textbook. The contributors call for routine use of CT scans and ultrasound to directly measure artery-narrowing plaque, super paramagnetic iron oxide procedures, near infrared spectography, coronary thermography, and other newly devised methods for early detection of atherosclerotic disorders suitable for detection sooner than the appearance of any clinical symptoms or signs recognized by today\'s criteria including those of the American College of Cardiology and the American Heart Association. The SHAPE strategy aims to aid in earlier detection, providing greater therapeutic opportunities for prevention and treatment. That strategy has been subject to some controversy as offering, perhaps, to a great deal too early. Is it yet time to alter U.S. guidelines? Comprehensive therapists can contribute better to the controversy after study of the extensive contents of this innovative book.

In the preface, Doctor Naghavi writes: "Existing risk factor based on stratifications e.g, the Framingham Risk Sore, have proven grossly in adequate...traditional methods must be replaced. The SHAPE initiative is an effort to move in this direction."

Doctor Naghavi is the author of many peer-reviewed publications, has invented and patented several medical devices, and founded the Volcano Corporation, the leading manufacturer of vulnerable plaque detection equipment. Currently, his research involves a digital thermal monitoring device to evaluate vascular function.
